Tag: Biocon
Benchmarks trade with minor losses; pharma shares slide | Capital Market...
Last Updated : Oct 15 2024 | 2:50 PM ISTThe domestic equity indices traded with limited losses in mid-afternoon. The Nifty traded...
Biocon Ltd spurts 1.41%, up for third straight session | Capital...
Last Updated : Oct 15 2024 | 1:31 PM ISTBiocon Ltd is quoting at Rs 351.4, up 1.41% on the day as...
Stock Market LIVE Updates: GIFT Nifty signals slow start for Sensex,...
Stock Market LIVE Updates, Monday, September 30, 2024: Markets in India were likely headed for a muted start, as indicated by GIFT Nifty...
Stocks To Watch: Adani Enterprises, RIL, Tata Motors, Zydus Life, Biocon...
Stock Market, BSE, Nifty, Capital(Photo: Shutterstock)5 min read Last Updated : Sep 30 2024 | 7:07 AM IST
Stocks to Watch, Monday, September...
Biocon inks deal with Tabuk Pharma to commercialize GLP -1 products...
Last Updated : Sep 27 2024 | 11:16 AM ISTBiocon said that it has signed a licensing and supply agreement with Tabuk...
Stock Alert: Infosys, Indian Bank, Escorts Kubota, Biocon, Jubilant Pharmova |...
Last Updated : Sep 27 2024 | 9:04 AM ISTStocks to watch:
Infosys announced strategic collaboration with Sally Beauty to bring enterprise scale...
Biocon signs licensing and supply agreement with Tabuk Pharmaceutical | Capital...
Last Updated : Sep 26 2024 | 7:16 PM ISTTo commercialize its GLP-1 products in MENA regionBiocon announced the signing of a...
Results from Biocon Biologics supports interchangeability of psoriasis cure | Company...
2 min read Last Updated : Sep 25 2024 | 5:41 PM IST
Biocon Biologics (BBL) presented positive results from two Phase-III clinical...
Biocon, PFC, Chambal Fert; top picks by Ajit Mishra of Religare...
2 min read Last Updated : Sep 05 2024 | 6:28 AM IST
Nifty: CMP: 25,198.70
The markets ended their gaining streak, losing nearly...
Biocon arm gets USFDA nod for chronic heart failure drug |...
Last Updated : Sep 02 2024 | 9:04 AM ISTBiocon Pharma, a wholly owned subsidiary of Biocon, has received approval of its...
